Oncology

Every day in Italy will find nearly 1,000 new cases of cancer. In recent years the percentage of healing have improved thanks to increased adhesion of the population in screening protocols and early diagnosis.

A significant proportion of cancers is hereditary (from 8% to 20% depending on the type) and genomic mutations can be passed from one generation to the next.

Our genetic tests identify mutations that predispose the development of some hereditary cancers and they also define the genetic causes of cancer in people who have already expressed pathology.

BRCA Test

BRCA Test

The test evaluates the predisposition of an individual to develop breast and ovarian cancer. BRCA 1 and BRCA 2 genes Breast cancer is the most common cancer in women. It is estimated that approximately 7-8% of patients with breast cancer have a inherited genetic predisposition. Mutations of BRCA1 and BRCA2 genes are associated to hereditary breast cancer, these […]

Discover More
ONCOCheck – Hereditary Cancer

ONCOCheck – Hereditary Cancer

ONCOCheck Hereditary Cancer is a genetic test designed to define genetic causes in individuals who have developed a cancerous pathology, or to define the risk of developing the disease. Knowing the genetic risk of a patient is important in order to implement the best surveillance and prevention measures. ONCOCheck Hereditary Cancer provides the most useful information […]

Discover More
ONCOCheck – Solid Tumor

ONCOCheck – Solid Tumor

  ONCOCheck Solid Tumor is a molecular analysis for the identification of SNVs and CNAs in frequently mutated genes in solid tumors. The test is designed using frequently occurring mutations (hotspots) in 26 genes. ONCOCheck Solid Tumor focuses on actionable hotspot mutations in a wide variety of solid tumors: this means they have either therapeutic […]

Discover More
ONCOCheck – Myeloid Leukemia

ONCOCheck – Myeloid Leukemia

ONCOCheck Myeloid Leukemia uses next generation sequencing (NGS) technology to targets mutations in 54 genes (tumor suppressor genes and oncogenic hotspots) involved in different onco-hematological disease: acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), chronic myelogenous leukemia (CML), chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML). The result is a single genetic […]

Discover More